RANTES deficiency attenuates autoantibody-induced glomerulonephritis

Journal of Clinical Immunology

Volumn 31, Issue 1, 2011, Pages 128-135

  Xie, Chun ^a   Liu, Kui ^a   Fu, Yuyang ^a   Qin, Xiangmei ^a   Jonnala, Geetha ^a   Wang, Tao ^a   Wang, Hong W ^a   Maldonado, Michael ^b   Zhou, Xin J ^a   Mohan, Chandra ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

DBA 1; genetics; lupus; RANTES

Indexed keywords

AUTOANTIBODY; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HISTOPATHOLOGY; IMMUNE COMPLEX NEPHRITIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INTERSTITIAL NEPHRITIS; MACROPHAGE; MALE; MOUSE; NEPHRITIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UREMIA;

ANIMALS; AUTOANTIBODIES; CHEMOKINE CCL5; FEMALE; GLOMERULONEPHRITIS; KIDNEY; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; PROTEINURIA; RABBITS;

EID: 79953873668     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9470-x     Document Type: Article

References (39)

1. Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, et al. A human T cell-specific molecule is a member of a new gene family. J Immunol. 1988;141:1018-25.
2. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine. 1991;3:165-83.
3. Brown KD, Zurawski SM, Mosmann TR, Zurawski G. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J Immunol. 1989;142:679-87. (Pubitemid 19039994)
4. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990;347:669-71. (Pubitemid 20356243)
5. Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN. Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol. 1995;101:398-407.
6. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem. 1993;268(8):5834-9. (Pubitemid 23090915)
7. Volin MV, Shah MR, Tokuhira M, Haines GK, Woods JM, Koch AE. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol. 1998;89:44-53. (Pubitemid 28457885)
8. Shahrara S, Proudfoot AE, Woods JM, Ruth JH, Amin MA, Park CC, et al. Amelioration of rat adjuvant-induced arthritis by Met- RANTES. Arthritis Rheum. 2005;52:1907-19. (Pubitemid 40852900)
9. Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett. 1997;57:117-20. (Pubitemid 27319323)
10. Barnes DA, Tse J, Kaufhold M, Owen M, Hesselgesser J, Strieter R, et al. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Investig. 1998;101:2910-9. (Pubitemid 28294601)
11. Okamoto H, Kamatani N. A CCR-5 antagonist inhibits the development of adjuvant arthritis in rats. Rheumatology. 2006;45:230-2. (Pubitemid 43160093)
12. Snowden N, Hajeer A, Thomson W, Ollier B. RANTES role in rheumatoid arthritis. Lancet. 1994;343:547-8.
13. Boiardi L, Macchioni P, Meliconi R, Pulsatelli L, Facchini A, Salvarani C. Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol. 1999;17:419-25. (Pubitemid 29343625)
14. Ellingsen T, Buus A, Kuno Mller B, Stengaard-Pedersen K. In vitro migration of mononuclear cells towards synovial fluid and plasma from rheumatoid arthritis patients correlates to RANTES synovial fluid levels and to clinical pain parameters. Scand J Rheumatol. 2000;29:216-21.
15. Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol. 1999;11:553-9. (Pubitemid 29179003)
16. Proudfoot AEI, Buser R, Borlat F, Alouani S, Soler D, Offord RE, et al. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors. J Biol Chem. 1999;274:32478-85.
17. Anders H-J, Vielhauer V, Kretzler M, Cohen CD, Segerer S, Luckow B, et al. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol. 2001;12:919-31. (Pubitemid 32378332)
18. Schadde E, Kretzler M, Banas B, Luckow B, Assmann K, Schlondorff D. Expression of chemokines and their receptors in nephrotoxic serum nephritis. Nephrol Dial Transplant. 2000;15:1046-53. (Pubitemid 30410380)
19. Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TNC, Salant DJ, et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 Is involved in crescent formation and interstitial fibrosis. J Exp Med. 1997;185:1371-80. (Pubitemid 27172917)
20. Krensky AM, Ahn Y-T. Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol. 2007;3:164-70. (Pubitemid 46327139)
21. Cockwell P, et al. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int. 1998;54:827-36.
22. Furuichi K, et al. Distinct expression of CCR1 and CCR5 in glomerular interstitial lesions of human glomerular disease. Am J Nephrol. 2000;20:291-9.
23. Xie C, Zhou XJ, Liu X, Mohan C. Enhanced susceptibility to endorgan disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum. 2003;48:1080-92. (Pubitemid 36418251)
24. Xie C, Sharma R, Wang H, Zhou XJ, Mohan C. Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol. 2004;172:5047-55. (Pubitemid 38456432)
25. Fu Y, Du Y, Mohan C. The experimental anti-GBM model as a tool for studying spontaneous lupus nephritis. Clin Immunol. 2007;124:109-18. (Pubitemid 47059046)
26. Tipping PG, Kitching AR. Glomerulonephritis, Th1 and Th2: what's new? Clin Exp Immunol. 2005;142(2):207-15.
27. Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, et al. Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis. Nephrology (Carlton). 2006;11 (3):219-25. (Pubitemid 43829441)
28. Eriksson C, Eneslatt K, Ivanoff J, Rantapaa-Dahlqvist S, Sundqvist KG. Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus. Lupus. 2003;12(10):766-74. (Pubitemid 37295812)
29. Kaneko H, Ogasawara H, Naito T, Akimoto H, Lee S, Hishikawa T, et al. Circulating levels of beta-chemokines in systemic lupus erythematosus. J Rheumatol. 1999;26(3):568-73. (Pubitemid 29125573)
30. Moore KJ, Wada T, Barbee SD, Kelley VR. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice. Kidney Int. 1998;53(6):1631-41. (Pubitemid 28243746)
31. Gao P, Zhou X-Y, Yashiro-Ohtani Y, Yang Y-F, Sugimoto N, Ono S, et al. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3. J Leukoc Biol. 2003;73:273-80. (Pubitemid 36158302)
32. Panzer U, Schneider A, Wilken J, Thompson DA, Kent SB, Stahl RA. The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int. 1999;56:2107-15. (Pubitemid 30004739)
33. Anders HJ, et al. CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol. 2003;170:5658-66.
34. Anders HJ, Vielhauer V, Frink M, Linde Y, Cohen CD, Blattner SM, et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Investig. 2002;109:251-9. (Pubitemid 34083745)
35. Anders HJ, Belemezova E, Elis V, Segerer S, Vielhauer V, Frink M, et al. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-FASlpr mice. J Am Soc Nephrol. 2004;15:1504-13. (Pubitemid 38679675)
36. Eia V, Luckow B, Vielhauer V, Siveke JT, Linde Y, Sergere S, et al. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol. 2004;15:337-47. (Pubitemid 38140774)
37. Turner J-E, Paust H-J, Steinmetz OM, Peters A, Meyer-Schwesinger C, Heymann F, et al. CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J Immunol. 2008;181:6546-56.
38. Ye DQ, et al. Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus. Arch Dermatol Res. 2005;297:108-13. (Pubitemid 41425040)
39. Mlynarski WM, et al. Risk of diabetic nephropathy in type I diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect. Diabetes. 2005;54:3331-5. (Pubitemid 43334391)